ArticleCureus2025
Delayed-Onset Hematomas Following Mohs Surgery in Patients Taking a Direct Oral Anticoagulant.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Direct factor Xa inhibitors or direct oral anticoagulants, like apixaban, are used to reduce the risk of stroke, deep vein thrombosis, and pulmonary embolism. It is essential that patients prescribed these drugs follow the instructions carefully. When a patient needs surgery and is on a direct oral anticoagulant, the question arises as to whether they should stop taking it before the elective surgery. There are currently no well-established guidelines instructing whether a patient should discontinue taking them before a Mohs procedure. A Mohs procedure is a precise surgery that removes skin cancers. We describe two cases of delayed-onset hematoma formation following Mohs micrographic surgery and reconstruction in patients taking direct oral anticoagulants not withheld prior to the procedure. Due to the possible uniqueness of late-onset hematoma formation greater than two weeks post-operatively in patients taking apixaban, we wanted to bring this event to the attention of other physicians. This report highlights the need to instruct patients on the possible complications of continuing the prescription and the importance of consulting the prescribing doctor before telling the patient to cease taking the drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.